
Jessica Jiping Yuen
Examiner (ID: 8749)
| Most Active Art Unit | 3749 |
| Art Unit(s) | 3749, 3742, 3404, 3762, 3743 |
| Total Applications | 2412 |
| Issued Applications | 1625 |
| Pending Applications | 153 |
| Abandoned Applications | 653 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18829669
[patent_doc_number] => 20230398193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => ASPARAGINASE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/032860
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -63
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032860
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032860 | ASPARAGINASE PROTEINS | Oct 18, 2021 | Pending |
Array
(
[id] => 19379376
[patent_doc_number] => 20240269246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => METHODS FOR TREATING CERVICAL DYSTONIA
[patent_app_type] => utility
[patent_app_number] => 18/031861
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031861 | METHODS FOR TREATING CERVICAL DYSTONIA | Oct 12, 2021 | Pending |
Array
(
[id] => 18784652
[patent_doc_number] => 20230372244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => Methods of Preparing Cell-Derived Vesicles
[patent_app_type] => utility
[patent_app_number] => 18/030535
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030535
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030535 | Methods of Preparing Cell-Derived Vesicles | Oct 11, 2021 | Abandoned |
Array
(
[id] => 20787498
[patent_doc_number] => 12661393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => BCG based vaccine compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/029599
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 16763
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029599
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029599 | BCG based vaccine compositions and methods of use thereof | Sep 30, 2021 | Issued |
Array
(
[id] => 18737956
[patent_doc_number] => 20230346858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => FEED AND COMPOSITION COMPRISING LACTIC ACID BACTERIA AND FATTY ACID
[patent_app_type] => utility
[patent_app_number] => 18/026464
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026464
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026464 | Feed and composition comprising lactic acid bacteria and fatty acid | Sep 20, 2021 | Issued |
Array
(
[id] => 17336432
[patent_doc_number] => 20220002763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => Production of alpha-(R)-(E)-(+)-ionone in recombinant Saccharomyces cerevisiae
[patent_app_type] => utility
[patent_app_number] => 17/479914
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479914 | Production of alpha-(R)-(E)-(+)-ionone in recombinant Saccharomyces cerevisiae | Sep 19, 2021 | Abandoned |
Array
(
[id] => 18844837
[patent_doc_number] => 20230407241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => A NOVEL PROBIOTIC STREPTOCOCCUS SALIVARIUS STRAIN AND ITS USES
[patent_app_type] => utility
[patent_app_number] => 18/023805
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023805
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023805 | A NOVEL PROBIOTIC STREPTOCOCCUS SALIVARIUS STRAIN AND ITS USES | Sep 2, 2021 | Pending |
Array
(
[id] => 20756221
[patent_doc_number] => 12648970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Compositions and methods of treatment comprising tumor-targeting bacteria and chemotherapy or immunotherapy agent
[patent_app_type] => utility
[patent_app_number] => 18/042070
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 61
[patent_no_of_words] => 12227
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042070
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042070 | Compositions and methods of treatment comprising tumor-targeting bacteria and chemotherapy or immunotherapy agent | Aug 17, 2021 | Issued |
Array
(
[id] => 19380925
[patent_doc_number] => 20240270795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => FUSION PROTEINS COMPRISING SARS-COV-2 RECEPTOR BINDING DOMAIN
[patent_app_type] => utility
[patent_app_number] => 18/020870
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020870
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020870 | FUSION PROTEINS COMPRISING SARS-COV-2 RECEPTOR BINDING DOMAIN | Aug 16, 2021 | Abandoned |
Array
(
[id] => 18612606
[patent_doc_number] => 20230279338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => SELF-DESTRUCTING SALMONELLA AS INNATE IMMUNITY ACTIVATOR TO IMPROVE FOOD SAFETY
[patent_app_type] => utility
[patent_app_number] => 18/018938
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018938 | SELF-DESTRUCTING SALMONELLA AS INNATE IMMUNITY ACTIVATOR TO IMPROVE FOOD SAFETY | Jul 28, 2021 | Pending |
Array
(
[id] => 18626676
[patent_doc_number] => 20230285476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => COMBINATION OF LACTOBACILLUS STRAINS AND USE THEREOF IN ANIMAL HEALTH
[patent_app_type] => utility
[patent_app_number] => 18/016622
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016622
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016622 | COMBINATION OF LACTOBACILLUS STRAINS AND USE THEREOF IN ANIMAL HEALTH | Jul 18, 2021 | Pending |
Array
(
[id] => 18567386
[patent_doc_number] => 20230257718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD FOR PRODUCTION OF VARICELLA ZOSTER VIRUS SURFACE PROTEIN ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 18/014296
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014296
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014296 | METHOD FOR PRODUCTION OF VARICELLA ZOSTER VIRUS SURFACE PROTEIN ANTIGEN | Jul 5, 2021 | Pending |
Array
(
[id] => 17428783
[patent_doc_number] => 20220056491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => MICROBIAL CONVERSION OF OILS AND FATS TO LIPID-DERIVED HIGH-VALUE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/341767
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17341767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/341767 | MICROBIAL CONVERSION OF OILS AND FATS TO LIPID-DERIVED HIGH-VALUE PRODUCTS | Jun 7, 2021 | Abandoned |
Array
(
[id] => 18059375
[patent_doc_number] => 20220390461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD FOR THE DETECTION OF CLOSTRIDIUM NEUROTOXINS USING A NOVEL SUBSTRATE
[patent_app_type] => utility
[patent_app_number] => 17/339263
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339263 | METHOD FOR THE DETECTION OF CLOSTRIDIUM NEUROTOXINS USING A NOVEL SUBSTRATE | Jun 3, 2021 | Pending |
Array
(
[id] => 17200417
[patent_doc_number] => 20210340512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Polypeptides Having DNase Activity
[patent_app_type] => utility
[patent_app_number] => 17/335188
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335188 | Polypeptides Having DNase Activity | May 31, 2021 | Abandoned |
Array
(
[id] => 16992223
[patent_doc_number] => 20210230643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => CONSTRUCTION OF A LACTOBACILLUS CASEI ETHANOLOGEN
[patent_app_type] => utility
[patent_app_number] => 17/228170
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228170 | CONSTRUCTION OF A LACTOBACILLUS CASEI ETHANOLOGEN | Apr 11, 2021 | Abandoned |
Array
(
[id] => 18321374
[patent_doc_number] => 20230119502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => Collagen Nucleation Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/915638
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915638 | Collagen Nucleation Inhibitors | Mar 29, 2021 | Abandoned |
Array
(
[id] => 18271941
[patent_doc_number] => 20230093183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ADENO-ASSOCIATED VIRUS CAPSID POLYPEPTIDES AND VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/801510
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801510 | ADENO-ASSOCIATED VIRUS CAPSID POLYPEPTIDES AND VECTORS | Feb 24, 2021 | Pending |
Array
(
[id] => 16885798
[patent_doc_number] => 20210171993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => POLYSACCHARIDE-OXIDIZING COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/164897
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164897 | POLYSACCHARIDE-OXIDIZING COMPOSITION AND USES THEREOF | Feb 1, 2021 | Abandoned |
Array
(
[id] => 18208667
[patent_doc_number] => 20230054926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => COMPOSITIONS AND METHODS FOR MICROBIAL TREATMENT OF SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/796433
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796433 | COMPOSITIONS AND METHODS FOR MICROBIAL TREATMENT OF SKIN DISORDERS | Jan 28, 2021 | Abandoned |